日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prophylactic Efficacy of CD388, a Novel Drug-Fc Conjugate, in a Human Influenza A/H3N2 Virus Challenge Model: A Randomized, Controlled Phase 2a Study

CD388(一种新型药物-Fc偶联物)在人甲型H3N2流感病毒攻击模型中的预防效果:一项随机、对照的2a期研究

Rojas, Roxana E; Equils, Ozlem; Villacian, Jorge; Mann, Alex; van Duijnhoven, Wilbert; Vingerhoets, Johan; Baguet, Tristan; Wang, Sy-Shi; Anandakumar, Arun; Anger, Antoinette; Tourneroche, Alice; Silva, Isabel Gonçalves; Flanagan, Shawn

Efficacy and Safety of Pimodivir Combined With Standard of Care in Hospitalized and Nonhospitalized High-Risk Adolescents and Adults With Influenza A Infection

匹莫地韦联合标准治疗方案治疗住院和非住院高危青少年及成人甲型流感感染的疗效和安全性

Leopold, Lorant; Vingerhoets, Johan; Deleu, Sofie; Nalpas, Catherine; Weber, Karin; van Dromme, Ilse; Lowson, David; Michiels, Bart; van Duijnhoven, Wilbert

Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S

单剂量Ad26.COV2.S疫苗的有效性和安全性最终分析

Sadoff, Jerald; Gray, Glenda; Vandebosch, An; Cárdenas, Vicky; Shukarev, Georgi; Grinsztejn, Beatriz; Goepfert, Paul A; Truyers, Carla; Van Dromme, Ilse; Spiessens, Bart; Vingerhoets, Johan; Custers, Jerome; Scheper, Gert; Robb, Merlin L; Treanor, John; Ryser, Martin F; Barouch, Dan H; Swann, Edith; Marovich, Mary A; Neuzil, Kathleen M; Corey, Lawrence; Stoddard, Jeffrey; Hardt, Karin; Ruiz-Guiñazú, Javier; Le Gars, Mathieu; Schuitemaker, Hanneke; Van Hoof, Johan; Struyf, Frank; Douoguih, Macaya

Impact of Integrase Sequences from HIV-1 Subtypes A6/A1 on the In Vitro Potency of Cabotegravir or Rilpivirine

HIV-1 A6/A1亚型整合酶序列对卡博特韦或利匹韦林体外效力的影响

Jeffrey, Jerry L; St Clair, Marty; Wang, Ping; Wang, Chunfu; Li, Zhufang; Beloor, Jagadish; Talarico, Christine; Fridell, Robert; Krystal, Mark; White, C Thomas; Griffith, Sandy; D'Amico, Ronald; Smith, Kimberly; Van Eygen, Veerle; Vingerhoets, Johan; Vandermeulen, Kati; Spreen, William; van Lunzen, Jan

Pharmacokinetics, Safety, and Antiviral Effects of Multiple Doses of the Respiratory Syncytial Virus (RSV) Fusion Protein Inhibitor, JNJ-53718678, in Infants Hospitalized With RSV Infection: A Randomized Phase 1b Study

呼吸道合胞病毒 (RSV) 融合蛋白抑制剂 JNJ-53718678 多剂量治疗 RSV 感染住院婴儿的药代动力学、安全性和抗病毒效果:一项随机 1b 期研究

Martinón-Torres, Federico; Rusch, Sarah; Huntjens, Dymphy; Remmerie, Bart; Vingerhoets, Johan; McFadyen, Katie; Ferrero, Fernando; Baraldi, Eugenio; Rojo, Pablo; Epalza, Cristina; Stevens, Marita

PrEP-001 prophylactic effect against rhinovirus and influenza virus - RESULTS of 2 randomized trials

PrEP-001 对鼻病毒和流感病毒的预防效果——两项随机试验的结果

Malcolm, Bruce Albert; Aerts, Caroline Anne; Dubois, Kristof Johan; Geurts, Frederik Joris; Marien, Kris; Rusch, Sarah; Van Dijck, Alex Henri; Verloes, Rene; Vingerhoets, Johan

TMC278, a next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI), active against wild-type and NNRTI-resistant HIV-1.

TMC278 是一种新一代非核苷类逆转录酶抑制剂 (NNRTI),对野生型和 NNRTI 耐药的 HIV-1 均有效

Azijn Hilde, Tirry Ilse, Vingerhoets Johan, de Béthune Marie-Pierre, Kraus Guenter, Boven Katia, Jochmans Dirk, Van Craenenbroeck Elke, Picchio Gaston, Rimsky Laurence T